STAT3 and myeloid sarcoma: The predicted upstream transcription factor STAT3 was elevated in the DN cells in MS (Fig. 6e, upper panel), while the expression of its antagonistic transcription factor STAT5A38–40 was reduced (Fig. 6e, lower panel).